Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:LVGO

Livongo Health (LVGO) Stock Price, News & Analysis

Livongo Health logo

About Livongo Health Stock (NASDAQ:LVGO)

Key Stats

Today's Range
$139.77
$139.77
50-Day Range
$136.67
$148.08
52-Week Range
$18.76
$151.05
Volume
N/A
Average Volume
3.04 million shs
Market Capitalization
$14.20 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications. Its products include Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company was formerly known as EosHealth, Inc. and changed its name to Livongo Health, Inc. in 2014. Livongo Health, Inc. was incorporated in 2008 and is headquartered in Mountain View, California.

Receive LVGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Livongo Health and its competitors with MarketBeat's FREE daily newsletter.

LVGO Stock News Headlines

Define Ventures Appoints Bruce Broussard as Venture Partner
This Bull Market Indicator called NVDA at $116
Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…
David P Fialkow's Net Worth
See More Headlines

LVGO Stock Analysis - Frequently Asked Questions

Livongo Health, Inc. (NASDAQ:LVGO) issued its quarterly earnings results on Wednesday, October, 28th. The company reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.11. The firm had revenue of $106.10 million for the quarter, compared to analysts' expectations of $95.57 million. Livongo Health had a positive trailing twelve-month return on equity of 0.29% and a negative net margin of 12.20%.

Livongo Health (LVGO) raised $230 million in an initial public offering on Thursday, July 25th 2019. The company issued 10,700,000 shares at a price of $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan acted as the underwriters for the IPO and Piper Jaffray, SVB Leerink, Canaccord Genuity, KeyBanc Capital Markets and Needham & Company were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Livongo Health investors own include NVIDIA (NVDA), Teladoc Health (TDOC), Tesla (TSLA), Meta Platforms (META), Block (SQ), PayPal (PYPL) and Salesforce (CRM).

Company Calendar

Last Earnings
10/28/2020
Today
11/23/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Computer Programming, Data Processing, & Other Computer Related
Sub-Industry
N/A
Current Symbol
NASDAQ:LVGO
CIK
N/A
Fax
N/A
Employees
471
Year Founded
N/A

Profitability

Net Income
$-55,270,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$170.20 million
Book Value
$5.37 per share

Miscellaneous

Free Float
N/A
Market Cap
$14.20 billion
Optionable
Not Optionable
Beta
1.81
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (NASDAQ:LVGO) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners